Skip to main content

Table 7 Baseline characteristics and surgical outcomes in the patients of BCLC C stage

From: Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients

 

Conversion treatment group (n=16)

Control group (n=21)

t/Z/χ2

P value

Age, years, n

  

0.03

0.57

 < 65

11

15

  

 ≥65

5

6

  

Sex, n

  

0.13

0.6

 Male

15

19

  

 Female

1

2

  

The operation time, min

236.06±63.83

195±63.72

1.94

0.06

The mean blood loss, ml

146.88±64.47

113.5±56.31

-1.47

0.14

The postoperative hospital stay, days

11.69±2.75

10.14±3.77

1.38

0.18

The abdominal drainage time, days

8.53±3.62

5.9±2.99

2.36

0.03

ΔRBC%

-8.6 (-17.4~-3.1)

-7.2 (-12.6~-1.2)

-1.42

0.16

ΔHB%

-8.3 (-16.3~-1.2)

-6.71 (-11.9~-1.4)

-1.02

0.31

ΔALT%

881.46(366.94~1820.15)

743.31(350.19~1263.12)

-0.89

0.37

ΔAST%

832.52(380.45~2341.99)

655.51(373.75~1088.99)

-0.64

0.52

Δ Bilirubin%

69.78 (34.81~120.02)

34.62 (-1.74~94.28)

-1.07

0.28

Δ Albumin%

-13.53 (-19.98~-4.19)

-21.59 (-26.1~-15.23)

-2.33

0.02

Postoperative complications

12 (n=9)

19 (n=12)

0.003

0.61

 Fever caused by infection

2

4

  

 Biliary leakage

1

0

  

 Hypoproteinemia

2

4

  

 Massive ascites

1

7

  

 Spontaneous bacterial peritonitis

1

1

  

 Hydrothorax

1

2

  

 Kaliopenia

3

0

  

 Pneumonia

0

1

  

 Incision seepage

1

0